By analyzing the flowerpot snake's unique genome, scientists are uncovering how the tiny reptile repairs its DNA and prevents harmful mutations. The findings provides valuable insights into genetic ...

At first glance, it looked like a genetic error — so severe it should have crippled the animal. But instead, it helped turn ...

Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...

The study, published in The Lancet, a team from the Moorfields Eye Hospital and University College London Institute of ...

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...

Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...

Learn more about whether CRISPR Therapeutics AG or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...